Taylor Cullen
Family · Portsmouth, VANPI 1346974540
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Boston Scientific at 45.3% of the total. Among family clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $66.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$6K
- Edwards Lifesciences$4K
- Medtronic$3K
- Novo Nordisk$249
- Novartis$182
- Johnson & Johnson$164
- plus $575 from 11 others
What the payments were for
- Travel & lodging$7,37855%
- Food & beverage$5,74743%
- Education$2432%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 56 | $6,054 |
| Edwards Lifesciences | 37 | $3,525 |
| Medtronic | 67 | $2,620 |
| Novo Nordisk | 4 | $249 |
| Novartis | 10 | $182 |
| Johnson & Johnson(2 entities) | 8 | $164 |
| Lantheus Medical Imaging, Inc. | 1 | $108 |
| Actelion Pharmaceuticals US, Inc. | 2 | $108 |
| Daiichi Sankyo Inc. | 3 | $75 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $67 |
| E.r. Squibb & Sons, L.L.C. | 3 | $48 |
| Boehringer Ingelheim | 2 | $41 |
| Teleflex LLC | 1 | $30 |
| Davol Inc. | 1 | $30 |
| Philips North America LLC | 1 | $26 |
| Amgen | 1 | $23 |
| Pfizer | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,368 in reported general payments places this provider in the 95th percentile of 4,332 family providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 43 | $227 |
| Metoprolol Succinate | 14 | $216 |
| Metoprolol Tartrate | 34 | $116 |
| Furosemide | 14 | $30 |
| Amlodipine Besylate | 14 | $6 |
Paid to pharmacies, not to this prescriber.
Other family in Portsmouth
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.